Catalyst Wire Dossier Catalyst Wire Dossier

bevaczizumab

bevacizumab · Hoffmann-La Roche / Genentech
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bevaczizumab, covering 2020-11-05 to 2020-11-05. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study [Phase 4]

See pricing